These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4758739)

  • 21. Hypocholesterolemic activity of colestipol in diabetes.
    Bandisode MS; Boshell BR
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):276-84. PubMed ID: 809240
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of colestipol, a new bile acid sequestrant, on the absorption of phenprocoumon in man.
    Harvengt C; Desager JP
    Eur J Clin Pharmacol; 1973 Jun; 6(1):19-21. PubMed ID: 4764368
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of colestipol hydrochloride on drug absorption in the rat. I. Aspirin, L-thyroxine, phenobarbital, cortisone, and sulfadiazine.
    Phillips WA; Schultz JR; Stafford WW
    J Pharm Sci; 1974 Jul; 63(7):1097-103. PubMed ID: 4851736
    [No Abstract]   [Full Text] [Related]  

  • 24. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.
    Glueck CJ; Ford S; Scheel D; Steiner P
    JAMA; 1972 Nov; 222(6):676-81. PubMed ID: 4562098
    [No Abstract]   [Full Text] [Related]  

  • 25. [Fecal excretion of neutral and acid sterols in patients with atherosclerosis with a progressive or stable course].
    Radmoskiĭ VG; Rabinovich PD
    Vopr Med Khim; 1981; 27(4):454-8. PubMed ID: 7293075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of changes in human cholesterol metabolism.
    Miettinen TA
    Ann Clin Res; 1970 Dec; 2(4):300-20. PubMed ID: 5493461
    [No Abstract]   [Full Text] [Related]  

  • 27. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
    Schonfeld G; Witztum J; Basich P
    Artery; 1982; 10(2):99-104. PubMed ID: 7092583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biphenabid (Probucol): a new hypocholesterolemic agent.
    Kalams Z; Dacquisto M; Kornett GS
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):692-4. PubMed ID: 5000716
    [No Abstract]   [Full Text] [Related]  

  • 29. [Long-term therapy of hypercholesteremia in diabetics with colestipol].
    Düntsch G
    Fortschr Med; 1981 Jan; 99(3):73-5. PubMed ID: 6781999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
    Xydakis AM; Guyton JR; Chiou P; Stein JL; Jones PH; Ballantyne CM
    Am J Cardiol; 2004 Sep; 94(6):795-7. PubMed ID: 15374793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of colestipol hydrochloride on cholesterol and bile acids absorption in the rat intestinal tract.
    Fujihashi T; Munekiyo K; Meshi T
    J Pharmacobiodyn; 1981 Aug; 4(8):552-8. PubMed ID: 7299619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma, bile and fecal sterols in relation to diet.
    Sodhi HS; Wood PD; Schlierf G; Kinsell LW
    Metabolism; 1967 Apr; 16(4):334-44. PubMed ID: 6024159
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypocholesterolemic effects of fatty acid bile acid conjugates (FABACs) in mice.
    Leikin-Frenkel A; Parini P; Konikoff FM; Benthin L; Leikin-Gobbi D; Goldiner I; Einarsson C; Gilat T
    Arch Biochem Biophys; 2008 Mar; 471(1):63-71. PubMed ID: 18167305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver scan in hyperlipoproteinemia.
    Sachs BA; Bardfeld PA; Bodian JE; Sugarman LA; Hellman L
    JAMA; 1974 Feb; 227(8):907-10. PubMed ID: 4590252
    [No Abstract]   [Full Text] [Related]  

  • 35. The metabolism of cholesterol in two hypercholesterolaemic patients treated with cholestyramine.
    Moutafis CD; Myant NB
    Clin Sci; 1969 Oct; 37(2):443-54. PubMed ID: 5359001
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of cholestyramine on the fecal excretion of intravenously administered cholesterol-4-14C and its degradation products in a hypercholesterolemic patient.
    Moore RB; Crane CA; Frantz ID
    J Clin Invest; 1968 Jul; 47(7):1664-71. PubMed ID: 5658594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Colestipol by hypercholesteremia in diabetics].
    Düntsch G
    Fortschr Med; 1977 Jun; 95(22):1492-6. PubMed ID: 873435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol gallstone formation and its regression in prairie dogs.
    Chang SH; Ho KJ; Taylor CB
    Arch Pathol; 1973 Dec; 96(6):417-26. PubMed ID: 4784872
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of colestipol on sterol metabolism in the rat.
    Takahashi M; Sarwal AN; Raicht RF; Cohen BI
    Lipids; 1980 Jun; 15(6):434-8. PubMed ID: 7401941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.